Literature DB >> 16951386

Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss.

Moo-Jin Baek1, Hyun-Min Park, Justin M Johnson, Cengiz Z Altuntas, Daniel Jane-Wit, Ritika Jaini, C Arturo Solares, Dawn M Thomas, Edward J Ball, Nahid G Robertson, Cynthia C Morton, Gordon B Hughes, Vincent K Tuohy.   

Abstract

Autoimmune sensorineural hearing loss (ASNHL) is the most common cause of sudden hearing loss in adults. Although autoimmune etiopathogenic events have long been suspected in ASNHL, inner ear-specific Ags capable of targeting T cell autoreactivity have not been identified in ASNHL. In this study, we show by ELISPOT analysis that compared with normal hearing age- and sex-matched control subjects, ASNHL patients have significantly higher frequencies of circulating T cells producing either IFN-gamma (p = 0.0001) or IL-5 (p = 0.03) in response to recombinant human cochlin, the most abundant inner ear protein. In some patients, cochlin responsiveness involved both CD4+ and CD8+ T cells whereas other patients showed cochlin responsiveness confined to CD8+ T cells. ASNHL patients also showed significantly elevated cochlin-specific serum Ab titers compared with both normal hearing age- and sex-matched control subjects and patients with noise- and/or age-related hearing loss (p < 0.05 at all dilutions tested through 1/2048). Our study is the first to show T cell responsiveness to an inner ear-specific protein in ASNHL patients, and implicates cochlin as a prominent target Ag for mediating autoimmune inner ear inflammation and hearing loss.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951386     DOI: 10.4049/jimmunol.177.6.4203

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease.

Authors:  Shresh Pathak; Elliot Goldofsky; Esther X Vivas; Vincent R Bonagura; Andrea Vambutas
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

2.  Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.

Authors:  Sherri M Jones; Nahid G Robertson; Shelly Given; Anne B S Giersch; M Charles Liberman; Cynthia C Morton
Journal:  Hear Res       Date:  2010-11-10       Impact factor: 3.208

3.  Impaired CD4+CD25+ regulatory T cell activity in the peripheral blood of patients with autoimmune sensorineural hearing loss.

Authors:  Ming Xia; Han Bing Zhang; Fang Liu; Hai Ying Yin; An Ting Xu
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-22       Impact factor: 2.503

4.  Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.

Authors:  Georgios K Tsirves; Paraskevi V Voulgari; Eleftherios Pelechas; Asimakis D Asimakopoulos; Alexandros A Drosos
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-30       Impact factor: 2.503

Review 5.  Immunosuppressive therapy for autoimmune inner ear disease.

Authors:  Maria C Buniel; Katie Geelan-Hansen; Peter C Weber; Vincent K Tuohy
Journal:  Immunotherapy       Date:  2009-05       Impact factor: 4.196

6.  Identification of pathogenic mechanisms of COCH mutations, abolished cochlin secretion, and intracellular aggregate formation: genotype-phenotype correlations in DFNA9 deafness and vestibular disorder.

Authors:  Seung-Hyun Bae; Nahid G Robertson; Hyun-Ju Cho; Cynthia C Morton; Da Jung Jung; Jeong-In Baek; Soo-Young Choi; Jaetae Lee; Kyu-Yup Lee; Un-Kyung Kim
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

7.  Vascular Pathophysiology in Hearing Disorders.

Authors:  Dennis R Trune; Anh Nguyen-Huynh
Journal:  Semin Hear       Date:  2012-08

8.  Experimental autoimmune breast failure: a model for lactation insufficiency, postnatal nutritional deprivation, and prophylactic breast cancer vaccination.

Authors:  Pavani Kesaraju; Ritika Jaini; Justin M Johnson; Cengiz Z Altuntas; Jessica J Gruden; Cagri Sakalar; Vincent K Tuohy
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

9.  A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction.

Authors:  Nahid G Robertson; Sherri M Jones; Theru A Sivakumaran; Anne B S Giersch; Sara A Jurado; Linda M Call; Constance E Miller; Stéphane F Maison; M Charles Liberman; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2008-08-12       Impact factor: 6.150

Review 10.  Corticosteroid therapy for hearing and balance disorders.

Authors:  Dennis R Trune; Barbara Canlon
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.